What you’ll learn:
- Navigating the discovery engine: Understand how Verily’s AI-native Pre platform streamlines the path from data discovery to insights
- Exploring specialized datasets: Get an inside look at our newest AI-ready datasets and how they support solving complex challenges:
- Transcripta Bio (Neurology/Rare Disease): Accelerate CNS and rare disease research using a functional genomics atlas that maps causal relationships in mature human neuronal models.
- Segmed (Oncology/Women’s Health): Support next-gen diagnostic development and biomarker discovery with high-fidelity imaging data and longitudinal records.
- RefinedScience (Hematology-Oncology): Identify new targets and stratify risk in hematologic malignancies via multi-omic profiling linked to longitudinal patient journeys.
Denise Meade
Vice President, Life Sciences & MedTech, Verily
Daniel Larson
Business Development & Strategy Manager, Transcripta Bio
Martin Willemink, MD, PhD
Co-founder & Chief Scientific Officer, Segmed
Grant Weller, PhD
Chief Technology Officer, RefinedScience
Unlock unique data and insights
Fill out the form below to download